Gaudium IVF

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0P8B01020
  • NSEID: GAUDIUMIVF
  • BSEID: 544709
INR
101.15
-2.05 (-1.99%)
BSENSE

Jun 11, 03:30 PM

BSE+NSE Vol: 2.52 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.52 lacs (764.30%) Volume

Shareholding (Mar 2026)

FII

6.70%

Held by 6 FIIs

DII

2.63%

Held by 2 DIIs

Promoter

71.29%

Why is Gaudium IVF and Women Health Ltd falling/rising?

11-Jun-2026

As of 10-Jun, Gaudium IVF and Women Health Ltd's stock price is currently at 103.20, reflecting a decline of 1.99%. Despite this drop, investor interest is increasing, as evidenced by a significant rise in delivery volume, although the stock shows mixed signals against its moving averages.

As of 10-Jun, Gaudium IVF and Women Health Ltd's stock price is falling, currently at 103.20, which reflects a decrease of 2.1 (-1.99%). This decline is evident as the stock has underperformed its sector by 1.5% today. Over the past week, the stock has decreased by 5.88%, significantly more than the Sensex, which fell by only 0.49%. Additionally, the stock has shown a substantial drop of 12.32% over the past month, while the Sensex has decreased by 4.33% in the same period.<BR><BR>Despite the current price drop, there is a notable increase in investor participation, with a delivery volume of 56.98k on June 9, which is up by 72.22% compared to the 5-day average. This indicates that while the stock price is falling, there is growing interest from investors. However, the stock's performance relative to its moving averages shows mixed signals; it is higher than the 100-day and 200-day moving averages but lower than the 5-day, 20-day, and 50-day moving averages, suggesting short-term weakness.<BR><BR>Overall, the combination of recent price declines, underperformance against the sector, and the broader market context contributes to the current downward trend in Gaudium IVF and Women Health Ltd's stock price.

View full answer

What does Gaudium IVF do?

11-Jun-2026

Gaudium IVF and Women Health Ltd is a micro-cap healthcare services company specializing in IVF treatments, with recent net sales of 30 Cr and a net profit of 8 Cr as of March 2026. Key financial metrics include a P/E ratio of 27.00 and a market cap of INR 766 Cr.

Overview: <BR>Gaudium IVF and Women Health Ltd operates in the healthcare services industry and is categorized as a micro-cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not provided. The latest quarterly results reported are for March 2026, showing net sales and profit.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 30 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 8 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 766 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 27.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.10 <BR>Return on Equity: 16.08% <BR>Price to Book: 5.03 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

View full answer

How big is Gaudium IVF?

11-Jun-2026

As of 10th June, Gaudium IVF and Women Health Ltd has a market capitalization of 766.00 Cr, with recent net sales of 113.51 Cr and a net profit of 27.83 Cr. The balance sheet for March 2025 shows shareholder's funds of 46.30 Cr and total assets of 88.51 Cr.

As of 10th June, Gaudium IVF and Women Health Ltd has a market capitalization of 766.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Gaudium IVF reported Net Sales of 113.51 Cr and a Net Profit of 27.83 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 46.30 Cr and Total Assets of 88.51 Cr.

View full answer

Should I buy, sell or hold Gaudium IVF and Women Health Ltd?

09-Jun-2026
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Flat results in Mar 26

 
2

With ROCE of 20.9, it has a Expensive valuation with a 4.5 Enterprise value to Capital Employed

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 751 Cr (Micro Cap)

stock-summary
P/E

26.00

stock-summary
Industry P/E

60

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

16.08%

stock-summary
Price to Book

4.93

Revenue and Profits:
Net Sales:
30 Cr
(Quarterly Results - Mar 2026)
Net Profit:
8 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
23.76%
0%
23.76%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Gaudium IVF for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Jun-2026 | Source : BSE

Gaudium IVF and Women Health Limited has informed the Exchange about Schedule of meet

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

29-May-2026 | Source : BSE

Audio recording of Q4 & FY26 Earnings Conference Call

Announcement under Regulation 30 (LODR)-Investor Presentation

29-May-2026 | Source : BSE

Investor Presentation on the Financial Results of the Company for the quarter and year ended March 31 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
14.59
Debt to EBITDA (avg)
0.65
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.59
Tax Ratio
23.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
9.32%
ROCE (avg)
20.92%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
26
Industry P/E
60
Price to Book Value
4.83
EV to EBIT
21.39
EV to EBITDA
19.94
EV to Capital Employed
4.47
EV to Sales
7.21
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
20.92%
ROE (Latest)
16.08%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 6 FIIs (6.7%)

Promoter with highest holding

Manika Khanna (70.73%)

Highest Public shareholder

Mukul Mahavir Agrawal (3.43%)

Individual Investors Holdings

14.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 56.24% vs -38.17% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 143.08% vs -64.78% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22.17",
          "val2": "14.19",
          "chgp": "56.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.27",
          "val2": "5.83",
          "chgp": "93.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.24",
          "val2": "1.12",
          "chgp": "10.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.73",
          "val2": "3.18",
          "chgp": "143.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "50.83%",
          "val2": "41.09%",
          "chgp": "9.74%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Gaudium IVF"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Gaudium IVF"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 21.32% vs 12.98% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 19.65% vs 11.96% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "71.58",
          "val2": "59.00",
          "chgp": "21.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "34.57",
          "val2": "27.86",
          "chgp": "24.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.36",
          "val2": "1.39",
          "chgp": "141.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "22.29",
          "val2": "18.63",
          "chgp": "19.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "48.30%",
          "val2": "47.22%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
22.17
14.19
56.24%
Operating Profit (PBDIT) excl Other Income
11.27
5.83
93.31%
Interest
1.24
1.12
10.71%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.73
3.18
143.08%
Operating Profit Margin (Excl OI)
50.83%
41.09%
9.74%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 56.24% vs -38.17% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 143.08% vs -64.78% in Dec 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
71.58
59.00
21.32%
Operating Profit (PBDIT) excl Other Income
34.57
27.86
24.08%
Interest
3.36
1.39
141.73%
Exceptional Items
0.00
0.00
Standalone Net Profit
22.29
18.63
19.65%
Operating Profit Margin (Excl OI)
48.30%
47.22%
1.08%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 21.32% vs 12.98% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 19.65% vs 11.96% in Mar 2025

stock-summaryCompany CV
About Gaudium IVF and Women Health Ltd stock-summary
stock-summary
Gaudium IVF and Women Health Ltd
Micro Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available